Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma.
about
Adenovirus vectors for gene therapy, vaccination and cancer gene therapyVirotherapy: cancer gene therapy at last?A dynamical systems model for combinatorial cancer therapy enhances oncolytic adenovirus efficacy by MEK-inhibitionOncolytic Virus-Based Immunotherapies for Hepatocellular Carcinoma.Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.Armed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes.A systematic comparison of the anti-tumoural activity and toxicity of the three Adv-TKsGene therapy of hepatocarcinoma: a long way from the concept to the therapeutical impact.Increasing the efficacy of oncolytic adenovirus vectorsDevelopment of viral vectors for gene therapy for chronic painParvovirus vectors for cancer gene therapy.Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC)Oncolytic virotherapy for advanced liver tumours.Oncolytic viral therapies.Experimental infections of humans with wild-type adenoviruses and with replication-competent adenovirus vectors: replication, safety, and transmission.Oncolytic viruses in the treatment of bladder cancerGene- and immunotherapy for hepatocellular carcinoma.Immunocompetent syngeneic cotton rat tumor models for the assessment of replication-competent oncolytic adenovirusRecent clinical progress in virus-based therapies for cancer.Immunotherapy for liver tumors: present status and future prospects.Oncolytic (replication-competent) adenoviruses as anticancer agents.AAV-mediated gene therapy for liver diseases: the prime candidate for clinical application?Clinical development directions in oncolytic viral therapy.Utilizing adenovirus vectors for gene delivery in cancer.Local drug delivery to a human pancreatic tumor via a newly designed multiple injectable needle.Potential usefulness of baculovirus-mediated sodium-iodide symporter reporter gene as non-invasively gene therapy monitoring in liver cancer cells: an in vitro evaluation.Expression of the coxsackie adenovirus receptor in neuroendocrine lung cancers and its implications for oncolytic adenoviral infection.A modified E2F-1 promoter improves the efficacy to toxicity ratio of oncolytic adenoviruses.Identification of adenovirus (ad) penton base neutralizing epitopes by use of sera from patients who had received conditionally replicative ad (addl1520) for treatment of liver tumors.Adenoviral p53 gene transfer and gemcitabine in three patients with liver metastases due to advanced pancreatic carcinoma.Reovirus as an experimental therapeutic for brain and leptomeningeal metastases from breast cancer.Neoadjuvant treatment of hepatic malignancy: an oncolytic herpes simplex virus expressing IL-12 effectively treats the parent tumor and protects against recurrence-after resection.Gene therapy of liver cancer.Review: Oncolytic virotherapy, updates and future directions.
P2860
Q27001601-6AAAC0C5-0B03-40AC-9489-F4EFB5CE4D95Q28066228-17ED5CBB-E5ED-4E66-832C-76B786F43F26Q28477181-29057BFC-B6A6-4AD3-893D-BFE4CAF3FA17Q33635033-BEA89277-20AA-4AF3-BBA8-907389CDD4E3Q34681207-3FF59ABD-D69B-40C2-A0C1-656FBC177C7FQ35043106-82C9DE37-5AF9-4BEC-88EA-138368DE9216Q35145614-7FD784A9-0225-48E6-B6FA-D1A038D649F4Q35208038-3103CC5B-A7DC-423A-B1F2-E6BD453ED6E1Q35261325-E8AC1178-2D1C-4F1D-85D0-A4C7E44CFADBQ35430864-46B881F6-1B49-44EA-ABAE-DAAC28248721Q35609780-E9157A33-A256-4338-87DE-4FF500A5C3B5Q35809215-35D940C5-A7E2-4E95-8689-109B33011F08Q35832074-44E0183C-AEC5-4364-93E3-9DDBED9CD176Q35852258-B52CCE98-6B7E-43D2-9A8C-36A5695E1951Q35883639-E63BE4D1-DDFD-4A20-93AB-E79DCB5EE9B8Q36147934-D5E5C7FF-66A3-48F9-9743-99B73B6D77F3Q36150432-8940EBE1-5339-4905-8B7E-6F2EBF280579Q36184357-9E606C45-7C03-4766-90C0-B44A9E32B3B6Q36627242-BAC0FB39-5125-4852-B90D-6CF9D3EB116CQ37144014-D12CB8DA-161C-4186-A552-72545D4B26CCQ37687415-AECEA55F-D8C1-40FB-9D24-E0948FE40D20Q37825907-9BB8EFD4-F18F-48E6-8945-25FA9441947EQ37857659-57FBACCE-AB2C-413A-BEEC-E41AF2B0F30BQ38176044-38097E92-B532-450A-82F6-36469EC2096FQ38292643-E55CFCA2-A32D-4762-BBD4-9D2C45E8BFDAQ39114748-4C397BE5-EAA6-4607-919D-0152485C6931Q39235688-B2EBF4E1-22B2-4BE4-B07B-D1683E35EECEQ39807606-B038620F-7BBC-48E1-8252-779A8EA9F589Q40008652-DFEAEB70-32CE-4A5D-BD54-ADF9BF5B1457Q40424880-E913463F-4DA2-4EDF-99F4-20814F1FDE0EQ40515050-E9DFE52B-6C9F-4BEE-B98A-AC5D217AE54DQ40663869-0BC11D24-09A4-422F-888A-280323A74CA5Q42726362-ABE0EE17-417C-4CAD-A08B-E2E0D2064096Q47160989-80EC8EBA-5D29-4923-9E04-31D805D87355
P2860
Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Clinical trial of E1B-deleted ...... for hepatocellular carcinoma.
@en
type
label
Clinical trial of E1B-deleted ...... for hepatocellular carcinoma.
@en
prefLabel
Clinical trial of E1B-deleted ...... for hepatocellular carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Clinical trial of E1B-deleted ...... for hepatocellular carcinoma.
@en
P2093
Ahmed Abd El Latif Abu Median
Catherine Sarraf
Hosny Salama
Ilia Isac Anis
Jack Hartwigsen
Joanna Nicholls
Nagy Habib
Ragai Mitry
Rasha Ahmed Abd Al Aziz
P2860
P2888
P304
P356
10.1038/SJ.CGT.7700431
P577
2002-03-01T00:00:00Z
P5875
P6179
1011742175